Keywords: b-ms, agreed, deal, buy, adnexus, 430m, drug

B-MS in agreed deal to buy Adnexus for $430M

Article | 01 October 2007

Print This

US drug major Bristol-Myers Squibb says it has signed a definitive agreement to acquire privately-held Adnexus Therapeutics, developer of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in